Merus
ExitedAntibody engineering to battle cancer
Total raised
€126M
€125,500,000
Funding rounds
3
Investors
5
distinct backers
Active since
2006-12
latest 2015-07
Funding by year
EUR raised per yearFunding rounds
3 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2015-08-01 | Series C | €73M | Life Sciences Partners,Novartis Venture Fund,Novo A,S,Sofinnova Partners | View deal → |
| 2013-10-01 | Series B | €31M | Life Sciences Partners,Novartis Venture Fund | View deal → |
| 2007-01-01 | Series A | €22M | Life Sciences Partners,Novartis Venture Fund | View deal → |
Exit
Type
acquisition
Date
Sep 2025
Value
€6.8B
Acquiror
Genmab (Denmark)
Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- Picnic€1.7BNetherlands · E-commerce
- Just Eat Takeaway€1.6BNetherlands · Foodtech
- Nebius€1.5BNetherlands · Cloud
- Roivant Sciences€1.2BSwitzerland · Healthtech